(Q72065225)
Statements
Didanosine compared with continued zidovudine therapy for HIV-infected patients with 200 to 500 CD4 cells/mm3. A double-blind, randomized, controlled trial. Canadian HIV Trials Network Protocol 002 Study Group (English)
J S Montaner
M T Schechter
A Rachlis
J Gill
R Beaulieu
C Tsoukas
J Raboud
B Cameron
H Salomon
L Dunkle
L Smaldone
M A Wainberg
1 October 1995